Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Evaluation of the Second Generation iStent Inject in Open-Angle Glaucoma Subjects on Two Preoperative Topical Ocular Hypotensive Medications

NCT03478293 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.

NCT NCT03478293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03478293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Evaluation of the Second Generation iStent Inject in Open-Angle Glaucoma Subjects on Two Preoperative Topical Ocular Hypotensive Medications
Lead sponsor
Glaukos Corporation
Phase
Not applicable
Overall status
Terminated
Start date
February 27, 2018
Completion date
December 30, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma (poag)